NO984739L - Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer - Google Patents

Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer

Info

Publication number
NO984739L
NO984739L NO984739A NO984739A NO984739L NO 984739 L NO984739 L NO 984739L NO 984739 A NO984739 A NO 984739A NO 984739 A NO984739 A NO 984739A NO 984739 L NO984739 L NO 984739L
Authority
NO
Norway
Prior art keywords
cyclopent
piperidines
indole
spiro
preparation
Prior art date
Application number
NO984739A
Other languages
English (en)
Norwegian (no)
Other versions
NO984739D0 (no
Inventor
Mark G Palermo
Gerard J O'malley
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO984739D0 publication Critical patent/NO984739D0/no
Publication of NO984739L publication Critical patent/NO984739L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO984739A 1996-04-10 1998-10-09 Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer NO984739L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63064196A 1996-04-10 1996-04-10
PCT/US1997/003864 WO1997037992A2 (en) 1996-04-10 1997-03-10 Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors

Publications (2)

Publication Number Publication Date
NO984739D0 NO984739D0 (no) 1998-10-09
NO984739L true NO984739L (no) 1998-12-09

Family

ID=24527997

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984739A NO984739L (no) 1996-04-10 1998-10-09 Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer

Country Status (18)

Country Link
EP (1) EP0892802B1 (zh)
JP (1) JP3615225B2 (zh)
KR (1) KR100270145B1 (zh)
CN (1) CN1233249A (zh)
AR (1) AR006553A1 (zh)
AT (1) ATE252581T1 (zh)
AU (1) AU708124B2 (zh)
BR (1) BR9708563A (zh)
CA (1) CA2251545C (zh)
DE (1) DE69725713T2 (zh)
DK (1) DK0892802T3 (zh)
ES (1) ES2207718T3 (zh)
HU (1) HUP9902755A3 (zh)
IL (1) IL126003A0 (zh)
NO (1) NO984739L (zh)
PT (1) PT892802E (zh)
WO (1) WO1997037992A2 (zh)
ZA (1) ZA972984B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物
CA2788656A1 (en) 2010-02-16 2011-08-25 Pfizer Inc. (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
AU2016353446B2 (en) 2015-11-12 2022-05-19 Afasci, Inc. Ion channel inhibitory compounds, pharmaceutical formulations and uses
AR116020A1 (es) 2018-09-03 2021-03-25 Bayer Ag COMPUESTOS DE 3,9-DIAZAESPIRO[5.5]UNDECANO COMO INHIBIDORES DE GGTasa I Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS
WO2020048827A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds
WO2020048828A1 (en) 2018-09-03 2020-03-12 Bayer Pharma Aktiengesellschaft 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds

Also Published As

Publication number Publication date
EP0892802B1 (en) 2003-10-22
CA2251545C (en) 2002-01-08
PT892802E (pt) 2004-03-31
DK0892802T3 (da) 2003-12-01
DE69725713D1 (de) 2003-11-27
AU1990997A (en) 1997-10-29
NO984739D0 (no) 1998-10-09
ATE252581T1 (de) 2003-11-15
HUP9902755A3 (en) 2000-05-29
IL126003A0 (en) 1999-04-11
WO1997037992A2 (en) 1997-10-16
KR20000005328A (ko) 2000-01-25
ZA972984B (en) 1997-11-03
JP3615225B2 (ja) 2005-02-02
EP0892802A1 (en) 1999-01-27
CN1233249A (zh) 1999-10-27
JP2002509520A (ja) 2002-03-26
BR9708563A (pt) 1999-08-03
AR006553A1 (es) 1999-09-08
HUP9902755A2 (hu) 2000-03-28
CA2251545A1 (en) 1997-10-16
AU708124B2 (en) 1999-07-29
DE69725713T2 (de) 2004-05-13
KR100270145B1 (ko) 2000-11-01
ES2207718T3 (es) 2004-06-01

Similar Documents

Publication Publication Date Title
NO20091761L (no) Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
MY131298A (en) 5-heteroyl indole derivatives
BG101806A (en) Indole derivatives as 5-ht receptor antagoniss
NO20005454L (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmåte for fremstilling derav
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
NO986111D0 (no) Anvendelse av K-252A derivat for behandling av perifere og sentrale nervefo
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
NO20021541L (no) 5-beta-sapogenin- og pseudosapogeninderivater samt deres anvendelse ved behandling av demens
NO20002787L (no) Nye forbindelser
NO985574L (no) FremgangsmÕter og preparater anvendelige for inhibering av angiogenese
FI956074A (fi) Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
NO963850L (no) Heterosykliske forbindelser, deres fremstilling og anvendelse
NO984739L (no) Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer
NO985671D0 (no) Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte for deres fremstilling og farmas°ytiske preparater som inneholder dem
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
TR199700956T1 (xx) Indazolkarboksamidler.
DE69828999D1 (de) 1-(4-(1-(4-fluorphenyl)-1h-indol-3-yl)1-butyl)-spiro-(isobenzofuran-1(3h),4'-piperidin)-hydrohalogenide
ATE315933T1 (de) Therapeutische behandlung von kardiovaskularen krankheiten
NO984624D0 (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
DK0888114T3 (da) Anvendelse af (+)-alfa-(2,3-dimethoxyphenyl)-1-[2-(4-flourphenyl)-ethyl]-4-piperidinmethanol til behandling af depressive lidelser og bipolare lidelser
PL318812A1 (en) Method of identifying compounds suitable for treating auto-aggressive diseases
NO991589D0 (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
NO975682L (no) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler